Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Cetrorelix (Cetrotide) vs Cosyntropin (Cortrosyn)
An educational, source-based comparison of Cetrorelix (Cetrotide) and Cosyntropin (Cortrosyn) — how each peptide works, what it's researched for, and what to know before going deeper.
GnRH antagonist used in IVF to prevent premature ovulation.
Synthetic decapeptide that competitively blocks pituitary GnRH receptors, preventing LH surge during controlled ovarian stimulation.
- IVF / controlled ovarian stimulation
- • FDA-approved.
- • Used under specialist supervision.
Synthetic peptide containing the first 24 amino acids of ACTH — retains full corticotropic activity. Stimulates adrenal cortisol release for diagnostic testing.
- Primary and secondary adrenal insufficiency diagnosis
- • FDA-approved.
- • Single diagnostic dose; very well tolerated.
Trial-evidence rating
Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.
FDA-approved with published clinical trial data.
FDA-approved with published clinical trial data.
Study-by-study comparison
| Peptide | Study | Source | Year | Summary |
|---|---|---|---|---|
| Cetrorelix (Cetrotide) | Cetrorelix in ART | Human Reproduction | 2000 | Effective prevention of premature LH surge with simpler protocol than long agonist. |
| Cosyntropin (Cortrosyn) | Low-dose vs standard cosyntropin stimulation | JCEM | 2008 | Comparison of 1 mcg vs 250 mcg testing for secondary adrenal insufficiency. |
Side-effect & safety grid
- FDA-approved.
- Used under specialist supervision.
- FDA-approved.
- Single diagnostic dose; very well tolerated.
Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.
Cetrorelix (Cetrotide) vs Cosyntropin (Cortrosyn) — Key differences
- Class: Cetrorelix (Cetrotide) is classified as GnRH Antagonist · Reproductive, while Cosyntropin (Cortrosyn) is Diagnostic · Endocrine.
- Primary research focus: Cetrorelix (Cetrotide) — ivf / controlled ovarian stimulation; Cosyntropin (Cortrosyn) — primary and secondary adrenal insufficiency diagnosis.
- Tag: FDA-Approved · Fertility vs FDA-Approved · Diagnostic.